Idiopathic nephrotic syndrome (INS) is the most common glomerular disease in childhood. For a long time, it was considered a clinically defined, non-specific entity whose treatment was primarily based on glucocorticoid sensitivity. However, new findings paint a more precise picture: Idiopathic nephrotic syndrome – especially the steroid-sensitive form – is to be understood in essential parts as an autoimmune-driven disease in which B-cell dysregulation, autoantibodies against podocytic antigens and genetic predispositions interact. This opens up a new paradigm in pathogenesis, diagnostics and therapy, paving the way for individualized approaches.
Autoren
- Tanja Schliebe
Publikation
- Nephrologie-Special
Related Topics
You May Also Like
- New perspectives for clinics and research
Ageing, cellular senescence and Parkinson’s disease
- From early intervention to individualization
The new guidelines at a glance
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- COPD therapy
Drug therapy – Update 2025
- Focus on prevention
Colorectal cancer screening – an update
- From symptom to diagnosis
Oncology – Thymoma
- Patient-centered rounds in medicine
Aligning care with the patient
- Shared decision making
 
						
						 
					 
			 
						 
						 
																	 
																	 
																	 
																	 
																	 
																	 
																	